Synopsis: Shares of BSE Limited (NSE: BSE) jumped over 4% to an intraday high of ₹2,735.50 on Thursday, March 5, 2026. The surge followed a regulatory filing where the exchange confirmed receiving a “nod” from SEBI to launch derivative contracts on two fresh indices: the SENSEX Next 30 and the BSE Focused Midcap. This move is a strategic attempt to narrow the gap with its rival, the NSE, in the high-growth derivatives segment.
BSE Shares Rally 4% as SEBI Approves New Index Derivatives
Dalal Street’s oldest exchange is entering a new phase of product expansion.
After the market closed on March 4, BSE informed investors that the Securities and Exchange Board of India (SEBI) granted permission to introduce Futures & Options (F&O) on two underserved segments of the market.
This approval opens the door to derivatives trading in areas that have long lacked structured financial instruments. This approval brings BSE’s total derivative basket to four indices, up from just two (Sensex and Bankex).
The New Indices: Targeted Exposure
The expansion allows traders to hedge and speculate on a wider variety of market caps:
- SENSEX Next 30: This index tracks the next 30 largest and most liquid companies in the BSE 100 that are not already part of the main SENSEX 30. It effectively captures the “second tier” of India’s blue-chip companies, including names like HAL, Suzlon Energy, and TVS Motor.
- BSE Focused Midcap: A more concentrated index consisting of 20 high-quality midcap stocks, providing a targeted alternative to the broader Nifty Midcap Select index.
Also Read: Tejas Networks Price Skyrockets 9% on New AI-Driven Product Launch
Strategic Rationale: Why This Matters for Investors
The approval comes at a time when SEBI has tightened rules on weekly expiries, limiting each exchange to only one benchmark index with a weekly cycle (BSE’s slot is occupied by the Sensex).
- Monthly Expiry Focus: Both the SENSEX Next 30 and Focused Midcap will offer cash-settled monthly futures and options. These will expire on the last Thursday of the month.
- Volume Diversification: By launching these products, BSE aims to reduce its reliance on “expiry-day spikes” and encourage institutional participation in longer-dated contracts.
- Revenue Growth: Analysts from Prabhudas Lilladher note that the derivatives segment has been a primary driver for BSE’s 174% YoY jump in Q3 net profit (₹602 crore). New indices provide a fresh runway for transaction fee growth.
BSE Stock Performance and Technical Levels
Despite a broad market sell-off earlier this week due to US-Iran tensions, BSE shares have shown resilience.
The stock is a “multibagger,” having delivered over 80% returns in the past 12 months.
| Metric | Value (March 5, 2026) |
| Current Market Price | ₹2,731.80 (Gain of 3.99%) |
| 52-Week High | ₹3,227 |
| Support Level | ₹2,580 (200-day EMA) |
| Resistance Level | ₹2,506.82 (50-day EMA) |
With the SENSEX Next 30 index currently hosting heavyweights that have high retail interest, the launch is expected to attract significant liquidity once the official trading dates are announced by the exchange.
Disclaimer: The views expressed are for informational purposes only and do not constitute financial advice. Investing in stocks and IPOs involves significant risk.forgeup.in is not liable for any financial losses. Always consult a certified investment advisor before making any decisions.